Annuloplasty System Market Report 2026

Annuloplasty System Market Overview

• Annuloplasty System market size has reached to $0.7 billion in 2025 • Expected to grow to $0.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: Increasing Prevalence Of Cardiovascular Diseases Fueling The Growth Of The Market Due To Aging Population And Rising Heart Conditions • Market Trend: Advanced Surgical Valves Simplify Implantation And Improve Durability • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Annuloplasty System Market?

Annuloplasty system is a medical device used in heart valve repair surgeries, specifically for the treatment of valve dysfunction. It involves the use of a ring or band that is placed around the heart valve annulus to reshape or reinforce it, ensuring proper valve closure. It is used to restore the normal function of the heart valve and prevent blood from flowing backward into the heart, improving heart function and patient outcomes. The main device types of annuloplasty systems are annular rings and bands and suture annuloplasty devices. Annular rings and bands refer to implantable medical devices used during heart valve repair surgeries, particularly in annuloplasty procedures. The procedure types include open-heart surgery, minimally invasive annuloplasty, and robot-assisted annuloplasty. The annuloplasty systems are used for different heart valves, such as the mitral, tricuspid, aortic, and pulmonary valves. catering to end users, including hospitals, ambulatory surgical centers, and cardiac care centers.

What Is The Annuloplasty System Market Growth Forecast?

The annuloplasty system market size is expected to see strong growth in the next few years. It will grow to $0.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive cardiac procedures, rising aging population with valve disorders, growing adoption of robotic cardiac surgery, expansion of transcatheter treatment options, continuous innovation in annuloplasty device design. Major trends in the forecast period include increasing adoption of minimally invasive valve repair techniques, growing use of robotic-assisted annuloplasty procedures, rising preference for flexible and adjustable annuloplasty devices, expansion of transcatheter annuloplasty systems, enhanced focus on long-term valve durability.

Global Annuloplasty System Market Segmentation

1) By Device Type: Annular Rings And Bands, Suture Annuloplasty Devices 2) By Procedure Type: Open Heart Surgery, Minimally Invasive Annuloplasty, Robotic Assisted Annuloplasty 3) By Valve Type: Mitral Valve, Tricuspid Valves, Aortic Valves, Pulmonary Valves 4) By End User: Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers Subsegments: 1) By Annular Rings And Bands: Rigid Annuloplasty Rings, Semi-Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Complete Annuloplasty Rings, Incomplete Annuloplasty Rings 2) By Suture Annuloplasty Devices: Adjustable Suture Annuloplasty Devices, Non-Adjustable Suture Annuloplasty Devices, Transcatheter Suture Annuloplasty Systems, Robotic-Assisted Suture Annuloplasty Devices

What Is The Driver Of The Annuloplasty System Market?

The increasing prevalence of cardiovascular diseases is expected to propel the growth of the annuloplasty system market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary heart disease, heart failure, stroke, and hypertension. The increasing prevalence of cardiovascular diseases is due to the aging population, as age-related wear and tear on the heart and blood vessels increases the risk of heart conditions. Annuloplasty systems aid in cardiovascular disease treatment by providing effective solutions for heart valve repair, restoring proper valve function, and improving blood flow. They enhance patient outcomes by offering minimally invasive options for valve restoration, reducing recovery time and surgical risks. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the annuloplasty system industry.

Key Players In The Global Annuloplasty System Market

Major companies operating in the annuloplasty system market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, MicroPort Scientific Corporation, Terumo Corporation, B. Braun Melsungen AG, B. Braile Biomedica, Affluent Medical, Micro Interventional Devices Inc., NeoChord Inc., BioVentrix Inc., CryoLife Inc., Genesse BioMedical, BioStable Science & Engineering Inc., FOC Medical S.A., Cardiac Implants LLC, Medtentia International Ltd., Corcym S.r.l.

Global Annuloplasty System Market Trends and Insights

Major companies operating in the annuloplasty system market are focusing on developing innovative products, such as next-generation surgical valves and devices, to enhance procedural efficiency and long-term patient outcomes. Next-generation surgical valves and devices refer to advanced, innovative medical devices designed to simplify implantation, reduce surgical complexity, and improve the precision and durability of valve repairs or replacements. For instance, in June 2024, Medtronic plc, a US-based medical technology company, launched the Avalus Ultra valve, a next-generation surgical aortic tissue valve. This innovative device simplifies implantation with its low-profile valve holder and durable polyetheretherketone (PEEK) base frame, improving surgical ease and long-term performance. It enhances blood flow dynamics and provides visibility for future valve-in-valve procedures.

What Are Latest Mergers And Acquisitions In The Annuloplasty System Market?

In July 2024, Affluent Medical SAS, a France-based medical device company, acquired Edwards Lifesciences Corporation for $16.3 million. With this acquisition, Affluent Medical aims to expand its footprint in the cardiovascular market by strengthening its heart valve solutions portfolio, supporting its strategic vision to accelerate the development of advanced therapies for heart disease and enhance patient outcomes. Edwards Lifesciences is a US-based medtech company specializing in annuloplasty systems for mitral and tricuspid valve repair to support heart valve restoration.

Regional Outlook

North America was the largest region in the annuloplasty system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Annuloplasty System Market?

The annuloplasty system market consists of sales of flexible annuloplasty rings, rigid annuloplasty rings, semi-rigid rings, adjustable bands, surgical tools, implantable devices, and associated accessories used in heart valve repair procedures. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.